DIABETIC KETOACIDOSIS: A COMMON DEBUT OF DIABETES AMONG AFRICAN AMERICANS WITH TYPE 2 DIABETES > 2017

본문 바로가기

접속자집계

오늘
1,605
전체
2,137,799
TEL:02-3789-7891
사이트 내 전체검색

Home >
2017

DIABETIC KETOACIDOSIS: A COMMON DEBUT OF DIABETES AMONG AFRICAN AMERIC…

작성자 채식영양
작성일 17-01-01 00:00 | 조회 0 | 댓글 0

본문

P. Vellanki and GE. Umpierrez (2017). DIABETIC KETOACIDOSIS: A COMMON DEBUT OF DIABETES AMONG AFRICAN AMERICANS WITH TYPE 2 DIABETES. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 23(8), 971-978. https://doi.org/10.4158/EP161679.RA

PubMed 28534682


[Abstract]
OBJECTIVE: More than half of African Americans (AA) with a new diagnosis of diabetic ketoacidosis have clinical and metabolic features of type 2 diabetes during follow-up. This particular presentation of diabetes has been termed as ketosis-prone type 2 diabetes (KPDM) or atypical diabetes.

METHODS: We review the epidemiology, diagnosis, pathophysiology, and acute and long-term management of AA with KPDM and compare these similarities to patients with type 2 diabetes.

RESULTS: In contrast to the long-term insulin requirement of auto-immune type 1 diabetes, patients with KPDM are able to discontinue insulin after a few months of therapy and maintain acceptable glycemic control for many years on either diet or oral agents. Patients with KPDM have significant impairment of both insulin secretion and insulin action at presentation; however, at the time of near-normoglycemia remission, insulin secretion and action improve to levels similar to hyperglycemic patients with ketosis-resistant type 2 diabetes. In the long term, however, patients with KPDM have a decline in β-cell function similar to patients with type 2 diabetes. Recent studies indicate that treatment with metformin and dipeptidyl peptidase-4 inhibitors can prolong the period of near-normoglycemia remission for several years compared to placebo therapy.

CONCLUSION: KPDM is a unique but common presentation of newly diagnosed African Americans with type 2 diabetes.

ABBREVIATIONS: A(+/-) = auto-antibody positive/negative AA = African Americans DKA = diabetic ketoacidosis FFA = free fatty acids G6PD = glucose-6-phosphate dehydrogenase GAD-65 = 65-kDA glutamic acid decarboxylase HBA1c = glycated hemoglobin A1c HHV8 = human herpes virus 8 HLA = human leukocyte antigen KPDM = ketosis-prone type 2 diabetes.

0
  • 페이스북으로 보내기
  • 트위터로 보내기
  • 구글플러스로 보내기

댓글목록 0

등록된 댓글이 없습니다.

Total 200
2017 목록
번호 제목 글쓴이 날짜 조회 추천
140 텍스트 An Exceptional Case of Diabetic Ketoacidosis 링크 채식영양 01-01 1 0
139 텍스트 Don't Forget Ketoacidosis 링크 채식영양 01-01 0 0
138 텍스트 SGLT2 inhibitors and diabetic ketoacidosis: data from the FD… 링크 채식영양 01-01 1 0
137 텍스트 Nivolumab-induced autoimmune diabetes mellitus presenting as… 링크 채식영양 01-01 1 0
136 텍스트 Markers of immune-mediated inflammation in the brains of you… 링크 채식영양 01-01 1 0
열람중 텍스트 DIABETIC KETOACIDOSIS: A COMMON DEBUT OF DIABETES AMONG AFRI… 링크 채식영양 01-01 1 0
134 텍스트 Euglycaemic ketoacidosis in a non-diabetic primigravida foll… 링크 채식영양 01-01 0 0
133 텍스트 Neonatal Diabetes: Case Report of a 9-Week-Old Presenting Di… 링크 채식영양 01-01 1 0
132 텍스트 Thyroid function test in diabetic ketoacidosis 링크 채식영양 01-01 0 0
131 텍스트 [Diabetic ketoacidosis with mild hyperglycemia associated wi… 링크 채식영양 01-01 1 0
130 텍스트 Diabetic Ketoacidosis as an Immune-related Adverse Event fro… 링크 채식영양 01-01 0 0
129 텍스트 Management of diabetic ketoacidosis - effect of a quality im… 링크 채식영양 01-01 1 0
128 텍스트 Effects of SGLT-2 inhibitors on diabetic ketoacidosis: A met… 링크 채식영양 01-01 1 0
127 텍스트 The Study of Different Clinical Pattern of Diabetic Ketoacid… 링크 채식영양 01-01 1 0
126 텍스트 Euglycaemic diabetic ketoacidosis in patients using sodium-g… 링크 채식영양 01-01 0 0
게시물 검색

한국채식정보. 대표:이광조ㅣsoypaper@hanmail.netㅣ대표전화: 02-3789-7891ㅣ서울시 용산구 갈월동 56-5. 일심빌딩 203호